WHO ICTRP trial

Prediction of therapeutic effect of microparticles on advanced lung cancer

ChiCTR1800020223 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR1800020223
Public title Prediction of therapeutic effect of microparticles on advanced lung cancer
Scientific title Prediction of therapeutic effect of microparticles on advanced lung cancer
Primary sponsor PLA General Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Diagnostic test
Phase Diagnostic New Technique Clincal Study
Countries China
Conditions Lung cancer
Interventions Gold Standard:Clinical outcome;Index test:microparticles
Registration date Dec 20, 2018
Target size Target condition:40;Difficult condition:0
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations